Seeking Alpha

A host of Wall Street firms weigh in on NuVasive (NUVA -34%), cutting their ratings after the...

A host of Wall Street firms weigh in on NuVasive (NUVA -34%), cutting their ratings after the company lowered its Q3 revenue outlook late yesterday. Barclay's downgrades the shares to Equalweight, JMP to Market Perform, First Analysis to Equal Weight, Summer Street to Neutral, BMO and RBC to Underperform, and Well Fargo to Market Perform. Wells also also hacked it's price target range on the shares to $15 - $16 from $29 - $31.
Comments (1)
  • anil92691
    , contributor
    Comments (375) | Send Message
     
    The influence that orthopedic reps have is amazing as we just saw see here. The sales reps have tight relationships with orthopedic surgeons to the point that they are unethical and will probable be illegal as the sunshine act gets enforced. Worse is the distribution companies that orthopedic surgeons have formed to make even more money over and above their usual medical practice and surgery centers.
    5 Oct 2012, 01:39 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|